发明授权
EP1976513B1 CYCLOALKYLAMINES AS MONOAMINE REUPTAKE INHIBITORS 有权
环烷基胺类称为单胺再摄取抑制剂

CYCLOALKYLAMINES AS MONOAMINE REUPTAKE INHIBITORS
摘要:
The invention relates to novel cyclohexylamine derivatives and their use in the treatment and/or prevention of central nervous system (CNS) disorders, such as depression, anxiety, schizophrenia and sleep disorder as well as methods for their synthesis. The invention also relates to pharmaceutical compositions containing the compounds of the invention, as well as methods of inhibiting reuptake of endogenous monoamines, such as dopamine, serotonin and norepinephrine from the synaptic cleft and methods of modulating one or more monoamine transporter.
公开/授权文献
信息查询
0/0